UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Convertible And Redeemable Series A-2 Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022	$ 313,187			$ 492,676	$ (179,497)	$ 8
Beginning balance, shares at Dec. 31, 2022			29,746,793
Beginning balance at Dec. 31, 2022		$ 152,928
Beginning balance, shares at Dec. 31, 2022		17,500
Net loss	(14,719)				(14,719)
Stock-based compensation	13,035			13,035
Dividend payment to the Series A-2 preferred stockholders	(4,100)	$ (4,100)		(4,100)
Common stock issued	$ 2,690			2,690
Common stock issued, shares	214,571		214,571
Accumulated other comprehensive income	$ 12					12
Ending balance at Mar. 31, 2023	310,105			504,301	(194,216)	20
Ending balance, shares at Mar. 31, 2023		17,500
Ending balance at Mar. 31, 2023		$ 152,928
Ending balance, shares at Mar. 31, 2023			29,961,364
Beginning balance at Dec. 31, 2023	321,252			531,831	(210,356)	(223)
Beginning balance, shares at Dec. 31, 2023			30,190,231
Beginning balance at Dec. 31, 2023		$ 152,928
Beginning balance, shares at Dec. 31, 2023		17,500
Net loss	(13,357)				(13,357)
Stock-based compensation	11,272			11,272
Redemption of Series A-2 preferred stock, shares		(5,833)
Redemption of Series A-2 preferred stock		$ (60,000)
Dividend payment to the Series A-2 preferred stockholders	(2,814)	$ (2,800)		(2,814)
Common stock issued	$ 8,154			8,154
Common stock issued, shares	427,631		427,631
Accumulated other comprehensive income	$ (35)					(35)
Ending balance at Mar. 31, 2024	$ 324,472			$ 548,443	$ (223,713)	$ (258)
Ending balance, shares at Mar. 31, 2024		11,667
Ending balance at Mar. 31, 2024		$ 92,928
Ending balance, shares at Mar. 31, 2024			30,617,862